Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GDC-6599 in chronic cough
NCT05660850Phase 2Completed
- Sponsor
- Genentech
- Start
- Mar 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of nedizantrep in chronic cough, sponsored by Genentech. Started Mar 2023; status: completed.
02
Drugs
nedizantrep
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT05660850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05660850.